These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20043463)

  • 1. Subdividing NSCLC: reflections on the past, present, and future of lung cancer therapy.
    Argiris A; Gadgeel SM; Dacic S
    Oncology (Williston Park); 2009 Nov; 23(13):1147-8, 1150. PubMed ID: 20043463
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced non-small-cell lung cancer: new data, therapy choices, and challenging decisions.
    Sandler AB
    Oncology (Williston Park); 2006 May; 20(6):626-8. PubMed ID: 16773846
    [No Abstract]   [Full Text] [Related]  

  • 3. [Non-small-cell bronchial cancers at stage III. Therapeutic strategy].
    Sculier JP; Quoix E
    Rev Mal Respir; 1998 Jun; 15(3 Pt 2):319-22. PubMed ID: 9690301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of non-small-cell lung cancer.
    Mulshine JL; Glatstein E; Ruckdeschel JC
    J Clin Oncol; 1986 Nov; 4(11):1704-15. PubMed ID: 2430072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the treatment of metastatic non-small-cell lung cancer: slow but steady!
    Ramnath N; Govindan R
    Clin Lung Cancer; 2009 Jul; 10(4):260-1. PubMed ID: 19632945
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advanced non-small-cell lung cancer: new effective therapeutic alternatives for tomorrow?].
    Pérol M
    Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S20-7. PubMed ID: 15211228
    [No Abstract]   [Full Text] [Related]  

  • 8. How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer.
    Kunitoh H; Suzuki K
    Br J Cancer; 2007 May; 96(10):1498-503. PubMed ID: 17473830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic pulmonary cytology: why all the fuss over "NSCLC"?
    Cohen MB; Weydert JA
    Cancer Cytopathol; 2011 Feb; 119(1):3-4. PubMed ID: 21319309
    [No Abstract]   [Full Text] [Related]  

  • 10. Issues at the cutting edge in stage III non-small-cell lung cancer.
    Green MR; Lilenbaum RC
    Ann Oncol; 1995; 6 Suppl 3():S33-6. PubMed ID: 8616112
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy tripleheader extends life for non-small cell lung cancer patients. Concurrent radiation, chemotherapy and lobectomy increase survival for those with NSCLC.
    Health News; 2005 Oct; 11(10):5-6. PubMed ID: 16250091
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of non-small cell lung cancer patients with performance status2 (PS2).
    Boukovinas I; Kosmidis P
    Lung Cancer; 2009 Jan; 63(1):10-5. PubMed ID: 18586349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Moro D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S22-4. PubMed ID: 11924237
    [No Abstract]   [Full Text] [Related]  

  • 15. [New developments in treatment of non-small cell lung cancer].
    Reinmuth N; Gröschel A; Reck M
    Pneumologie; 2013 Nov; 67(11):634-8. PubMed ID: 24198238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimal survival after chemoradiation therapy for "non-bulky" stage IIIA NSCLC: what are the implications?
    Grannis FW
    Ann Thorac Surg; 2009 Apr; 87(4):1320; author reply 1320-1. PubMed ID: 19324191
    [No Abstract]   [Full Text] [Related]  

  • 18. Thoracic Oncology: Current Standard Therapy and Future Developments.
    Stinchcombe TE; Bradley JD
    J Clin Oncol; 2022 Feb; 40(6):527-529. PubMed ID: 34985922
    [No Abstract]   [Full Text] [Related]  

  • 19. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society.
    Am J Respir Crit Care Med; 1997 Jul; 156(1):320-32. PubMed ID: 9230769
    [No Abstract]   [Full Text] [Related]  

  • 20. Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?
    Langer CJ; Wakelee H; Schiller J; Choy H; Shepherd F; Vokes EE; Adjei AA; Baas P; Saijo N; Gandara DR
    Clin Lung Cancer; 2008 Mar; 9(2):85-91. PubMed ID: 18501094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.